Table 1 Clinicopathological characteristics of patients with bladder cancer
From: Prognostic significance of immunoscore related markers in bladder cancer
Characteristics | Â | N (%) | Â |
|---|---|---|---|
Age (years) |  |  | Mean (min–max): 66.96 ± 11.65 (40–87) Median: 68.00 |
Survival | Alive | 45 (52.9%) | Â |
Dead | 40 (47.1%) | Â | |
Overall survival (month) |  |  | Mean (min–max): 30.9 ± 19.98(1.1–67.73) Median: 24.07 |
T-stage | Ta | 4 (4.7%) | Â |
T1 | 27 (31.8%) | Â | |
T2 | 33 (38.8%) | Â | |
T3 | 9 (10.6%) | Â | |
T4 | 12 (14.1%) | Â | |
TNM-stage | 0 | 5 (5.9%) | Â |
1 | 26 (30.6%) | Â | |
2 | 28 (32.9%) | Â | |
3 | 26 (30.6%) | Â | |
4 | 0 (0%) | Â | |
Histological grade | Low | 27 (32.5%) | Â |
High | 56 (67.5%) | Â | |
Lymphovascular invasion | Positive | 18 (21.2%) | Â |
Negative | 63 (74.1%) | Â | |
Unreported | 4 (4.7%) | Â | |
Lymph node status | Not involved | 36 (75.0%) | Â |
Involved | 12 (25.0%) | Â | |
Unreported* | 37 | Â | |
Perineural invasion | Positive | 28 (32.9%) | Â |
Negative | 55 (64.7%) | Â | |
Unreported | 2 (2.4%) | Â | |
Muscle invasion | Positive | 54 (63.5%) | Â |
Negative | 31 (36.5%) | Â |